GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) » Definitions » EBITDA Margin %

Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) EBITDA Margin % : 26.26% (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Macro Group Pharmaceuticals (Macro Capital) Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Macro Group Pharmaceuticals (Macro Capital) Co's EBITDA for the three months ended in Sep. 2024 was E£43.0 Mil. Macro Group Pharmaceuticals (Macro Capital) Co's Revenue for the three months ended in Sep. 2024 was E£164.0 Mil. Therefore, Macro Group Pharmaceuticals (Macro Capital) Co's EBITDA margin for the quarter that ended in Sep. 2024 was 26.26%.


Macro Group Pharmaceuticals (Macro Capital) Co EBITDA Margin % Historical Data

The historical data trend for Macro Group Pharmaceuticals (Macro Capital) Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Macro Group Pharmaceuticals (Macro Capital) Co EBITDA Margin % Chart

Macro Group Pharmaceuticals (Macro Capital) Co Annual Data
Trend Dec20 Dec21 Dec22
EBITDA Margin %
42.45 35.54 34.97

Macro Group Pharmaceuticals (Macro Capital) Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.46 16.04 38.97 -0.73 26.26

Competitive Comparison of Macro Group Pharmaceuticals (Macro Capital) Co's EBITDA Margin %

For the Household & Personal Products subindustry, Macro Group Pharmaceuticals (Macro Capital) Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Macro Group Pharmaceuticals (Macro Capital) Co's EBITDA Margin % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Macro Group Pharmaceuticals (Macro Capital) Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Macro Group Pharmaceuticals (Macro Capital) Co's EBITDA Margin % falls into.


;
;

Macro Group Pharmaceuticals (Macro Capital) Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Macro Group Pharmaceuticals (Macro Capital) Co's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=255.132/729.612
=34.97 %

Macro Group Pharmaceuticals (Macro Capital) Co's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=43.047/163.956
=26.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Macro Group Pharmaceuticals (Macro Capital) Co  (CAI:MCRO) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Macro Group Pharmaceuticals (Macro Capital) Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Macro Group Pharmaceuticals (Macro Capital) Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Macro Group Pharmaceuticals (Macro Capital) Co Business Description

Traded in Other Exchanges
N/A
Address
83, Al Moltaka Al Arabi, Sheraton, Cairo, EGY
Macro Group Pharmaceuticals (Macro Capital) Co is principally engaged in the manufacture and sale of cosmeceutical and ventured into nutraceutical products.

Macro Group Pharmaceuticals (Macro Capital) Co Headlines